PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapyJun Li(Union Hospital), Liangliang Shi(Union Hospital)Cancer Immunology ImmunotherapyAugust 26, 202210.1007/s00262-022-03282-6Cited by 33SaveCiteExport RISWatch citationsRelated PapersLong non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression|Cell Death and Disease|2019|77Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor|Carcinogenesis|2012|52